Alzheimer’s blood test around ages 53-69 may help detect early cognitive decline
Posted:
One tool that doctors are beginning to use to help predict a person’s Alzheimer’s disease risk in its earliest stages is through blood tests that search for specific biomarkersTrusted Source in the blood.
Now, a new study published in The Lancet,Trusted Source primarily funded by the National Institutes of Health (NIH), has found that these biomarker blood tests may also help doctors detect very early signs of cognitive decline in midlife adults without a dementia diagnosis.
AI-driven billing for more medically complex inpatient stays has resulted in nearly $1 billion in additional healthcare costs over the last two years, according to new analysis by the Blue Cross Blue Shield Association.
More than 60% of hospitals and…
An artificial intelligence (AI) algorithm increased aneurysm detection, identifying 55 true-positive brain aneurysms that radiologists had missed, representing a 39% relative increase in detection.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us